๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cytogenetic features of childhood acute lymphoblastic leukemia: A concordance study and a pediatric oncology group study

โœ Scribed by Julie A. Katz; Linda D. Taylor; Andrew Carroll; Frederick F.B. Elder; Donald H. Mahoney

Book ID
119104869
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
480 KB
Volume
55
Category
Article
ISSN
0165-4608

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

RAS gene mutations in childhood acute my
RAS gene mutations in childhood acute myeloid leukemia: A pediatric oncology group study
โœ Dr. Bert Vogelstein; Dr. Curt I. Civin; Antonette C. Preisinger; Jeffrey P. Kris ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 336 KB

Mutations at codon I 2, I 3, and 6 I of the HRAS, KRAS, and NRASgenes were evaluated in 99 cases of pediatric acute myeloid leukemia (AML) using oligonucleotide hybridization to polymerase chain reacted derived products. Twenty-four mutations were identified in the NRAS gene, I 3 in the KRAS gene, a

Deoxycoformycin treatment for childhood
Deoxycoformycin treatment for childhood T-cell acute lymphoblastic leukemia early in second remission: A pediatric oncology group study
โœ Winick, Naomi ;Buchanan, George R. ;Murphy, Sharon B. ;Yu, Alice ;Boyett, James ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 552 KB

2-Deoxycoformycin (DCF) was added to an intensive Pediatric Oncology Group protocol (#8303) for children with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma in first relapse. Twenty-seven patients received one or more courses of DCF at 15 mg/m2/day as a 3-day continuous infusio